U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06848309) titled 'Dissecting Human Immune Responses to Infection with Influenza or SARS-CoV-2' on Feb. 12.
Brief Summary: The purpose of this study is to evaluate the virus-specific immune response in people who are symptomatic with confirmed influenza or COVID-19. We will study the immune response of people who have and who have not been vaccinated with the seasonal influenza and COVID-19 vaccines within the past year. All participants will have data collected and blood, saliva, and nasal swabs performed at five separate visits; 1) at study enrollment, 2) on study day 7, 3) on or between study days 10 to 28, 4) on study day 90, and 5) on study day 1...